Followers | 32 |
Posts | 6654 |
Boards Moderated | 0 |
Alias Born | 01/21/2005 |
Monday, May 04, 2009 6:58:28 PM
Monday , May 04, 2009 18:08ET
LOUISVILLE, Ky., May 04, 2009 (BUSINESS WIRE) -- --First Quarter EPS Guidance Range was $0.40 to $0.50
--Company Maintains 2009 EPS Range of $1.35 to $1.45
--Company Provides Second Quarter 2009 EPS Guidance of $0.28 to $0.38
Kindred Healthcare, Inc. (the "Company") (NYSE:KND) today announced its operating results for the first quarter ended March 31, 2009. All financial and statistical information included in this press release reflects the continuing operations of the Company's businesses for all periods presented unless otherwise indicated.
First Quarter Highlights:
-- Consolidated revenues rose 3% to $1.1 billion
-- Each operating division reported revenue growth compared to last year
-- Diluted earnings per share grew 36% to $0.57 compared to last year's $0.42
-- Earnings growth was driven by operating income growth in all three divisions and lower corporate overhead
-- Consolidated operating income grew 7% to $157 million
-- First quarter capital-related costs were flat with the first quarter of 2008
-- Hospital operating margins improved
-- Reported admissions declined 2% from last year partly resulting from leap year in 2008
-- Same-store aggregate admissions declined 1%
-- Same-store non-government admissions grew 12%
-- Nursing center results were in line with expectations despite softer volumes
-- Revenue mix and overall occupancy were relatively unchanged from last year
-- Annualized employee turnover declined to 38% from 48% in the first quarter of 2008
-- Peoplefirst operating income grew 35% in the quarter
-- Revenue growth and productivity improvements drove $4 million increase in operating income
--------->> http://www.knobias.com/story.htm?eid=3.1.6bb6f04fa5bd0541f2f7c047b4fd6696fbf5c5a2fa0533bdd10766051b7dd762
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM